Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

P2Y1 Activators

P2Y1 Activators belong to a class of chemical compounds that possess the unique ability to interact with and modulate the activity of the P2Y1 receptor. The P2Y1 receptor is a member of the P2Y family of G protein-coupled receptors (GPCRs) that are activated by purinergic signaling molecules, primarily adenosine triphosphate (ATP) and its derivatives. These receptors are widely distributed in various tissues and play essential roles in cellular signaling, particularly in responses to extracellular nucleotides. The P2Y1 receptor, when activated by ATP or other nucleotides, triggers intracellular signaling cascades, which can lead to various cellular responses, including calcium mobilization, cell migration, and neurotransmitter release. P2Y1 activators are compounds that can influence the activation, binding properties, or downstream signaling of the P2Y1 receptor, affecting cellular processes mediated by purinergic signaling. The mechanism of action of P2Y1 activators typically involves their capacity to interact with the P2Y1 receptor and modulate its activation state or downstream signaling events. When extracellular nucleotides like ATP bind to the P2Y1 receptor, it undergoes a conformational change that activates intracellular signaling pathways through G protein coupling. Activators may enhance or inhibit this activation by binding directly to the receptor and either stabilizing or altering its conformation. Additionally, they may impact the downstream signaling events mediated by the activated P2Y1 receptor, such as calcium mobilization or the activation of specific kinases, which can further regulate cellular responses. Understanding the properties and effects of P2Y1 activators is significant in the field of cell signaling and physiology, as it provides insights into the molecular mechanisms that govern purinergic signaling and its role in various physiological and pathophysiological processes. It contributes to our understanding of how specific compounds can modulate cellular responses mediated by purinergic receptors and extracellular nucleotides.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

2-Methylthio-ADP trisodium salt

475193-31-8sc-203464
10 mg
$838.00
5
(1)

2-Methylthio-ADP trisodium salt is a selective agonist for P2Y1 receptors, distinguished by its unique methylthio modification that enhances binding affinity. This compound initiates distinct signaling cascades, influencing platelet activation and vascular responses. Its trisodium salt form improves solubility and stability, allowing for efficient interaction with cellular membranes. The compound's kinetic profile supports rapid receptor activation, making it a key player in purinergic signaling dynamics.

BzATP triethylammonium salt

112898-15-4sc-203862
5 mg
$156.00
4
(1)

BzATP triethylammonium salt serves as a potent P2Y1 receptor agonist, characterized by its triethylammonium moiety that enhances membrane permeability and receptor engagement. This compound triggers specific intracellular signaling pathways, leading to calcium mobilization and cellular responses. Its unique structure promotes rapid kinetics, facilitating swift receptor activation and downstream effects. The compound's solubility profile further supports effective interactions with lipid bilayers, optimizing its bioavailability in various environments.

NF 546

1006028-37-0sc-361275
sc-361275A
10 mg
50 mg
$550.00
$2000.00
(0)

NF546 is a selective P2Y11 agonist but also shows activity at P2Y1 receptors, highlighting the complexity of P2Y receptor pharmacology.

NF 157

104869-26-3sc-204125
sc-204125A
1 mg
5 mg
$500.00
$2040.00
1
(0)

NF157 is primarily a P2Y11 antagonist but can modulate P2Y1 receptor activity indirectly through its effects on related signaling pathways.

Adenosine Kinase Inhibitor Inhibitor

214697-26-4sc-202900
5 mg
$443.00
9
(1)

Adenosine Kinase Inhibitor can increase extracellular adenosine levels, indirectly modulating P2Y1 receptor activity through adenosine receptor pathways.